in Newswire September 20, 2019

Class Action: Drug Makers Conspired to Overcharge for Diabetes Medication Glumetza [UPDATE]

by Erin Gilmore

Last Updated on October 1, 2019

Meijer, Inc. et al. v. Bausch Health Companies Inc. et al.

Filed: September 18, 2019 § 3:19-cv-05822

A proposed class action lawsuit out of California claims the prices of type 2 diabetes medication Glumetza and its generic version have skyrocketed due to an anticompetitive conspiracy executed by the drugs’ manufacturers.

Last Updated on October 1, 2019 — 2:10 PM

Erin Gilmore

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.